Prognostic value of tissue-polypeptide specific antigen (TPS) in bladder cancer

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3713-3716

  Menendez, Violeta ^a,e   Galan, Juan Antonio ^a   Fernandez Suarez, Antonio ^b   Lopez, Susana ^c   Alcover, Juan ^d   Calpena, Rafael ^c   Filella, Xavier ^d  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e NONE   (Spain)

Author keywords

Bladder tumors; Cytokeratins; TPS; Tumor markers

Indexed keywords

CYTOKERATIN 18; POLYCLONAL ANTIBODY; TISSUE POLYPEPTIDE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLOOD LEVEL; CANCER GRADING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOADSORBENT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RELAPSE; TUMOR RECURRENCE; TUMOR VOLUME; URINE CYTOLOGY;

HUMANS; PEPTIDES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0036875584     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Moll R, Franke WW, Schiller DL, Geiger B and Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31(1): 11-24, 1982.
2. Nathrath WB, Heidenkummer P, Bjorklund V and Bjorklund B: Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unifixed, methanol-, ethanol-, and formalin-fixed tissues. J Histochem Cytochem 33(2): 99-109, 1985.
3. Fetissof F, Serres G and Haillot O: Cytokeratins and transitional epithelium of the bladder. Particular distribution of cytokeratins. Arch Anat Cytol Pathol 38(4): 159-62, 1990.
4. Southgate J, Harnden P and Trejdosiewicz LK: Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol 14(2): 657-64, 1999.
5. Koch OM, Applehans N and von Eiff M: Tumor-markers in bronchoalveolar lavage of patients with lung cancer and other benign pulmonary diseases. IATMO Stockholm. Abstract 21: 19-23, 1988.
6. Glimelius B, Hoffman K, Einarsson R, Pahlman L and Graf W: Monitoring palliative chemotherapy in advanced gastrointestinal cancer using serial tissue polypeptide specific antigen (TPS) measurements. Acta Oncologica 35(2): 141-8, 1996.
7. Harlozinska A, Sedlaczek P, van Dalen A, Rozdolski K and Einarsson R: TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms. Anticancer Res 17(6D): 4473-8, 1997.
8. Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M and Oehr P: Serum TPS versus TPA in Egyptian bladder cancer patients. Int J Biol Markers 8(4): 221-6, 1993.
9. Loening S, Narayana A, Yoder L, Slymen D, Weinstein S, Penick G and Culp D: Factors influencing the recurrence rate of bladder cancer. J Urol 123(1): 29-31, 1980.
10. Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL and Debruyne FM: Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 150(1): 60-4, 1993.
11. Lutzeyer W, Rubben H and Dahm H: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 127(2):
12. Raghavan D, Shipley WU, Garnick MB, Russell PJ and Richie JP: Biology and management of bladder cancer. N Engl J Med 322(16): 1129-38, 1990.
13. Wiener HG, Vooijs GP and van't Hof-Grootenboer B: Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37(2): 163-9, 1993.
14. Moreno Sierra J, Maestro de las Casa ML, Ortega Heredia MD, Blanco Jimenez E, Hermida Gutierrez J and Resel Estevez L: Guantificacion serica y tisular de antigeno polipeptidico tisular (TPS) en el carcinoma transicional de vejiga. Arch Esp Urol 47: 979-84, 1994.
15. Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR and Whitmore WF Jr: Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J Urol 141(1): 22-9, 1989.
16. Helpap B, Vogel J, Oehr P and Adolphs HD: Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia/dysplasia of urinary bladder mucosa. Virchows Arch A Pathol Anat Histopathol 406(3): 309-22, 1985.
17. Maulard-Durdux C, Toubert ME, Hennequin C and Housset M: Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study. J Clin Oncol 15(12): 3446-50, 1997.